Cargando…
Genome maintenance in retinoblastoma: Implications for therapeutic vulnerabilities
Retinoblastoma (RB) is a pediatric ocular malignancy that is initiated mostly by biallelic inactivation of the RB transcriptional corepressor 1 (RB1) tumor suppressor gene in the developing retina. Unlike the prevailing prediction based on multiple studies involving RB1 gene disruption in experiment...
Autores principales: | Lee, Chunsik, Kim, Jong Kyong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9073582/ https://www.ncbi.nlm.nih.gov/pubmed/35527780 http://dx.doi.org/10.3892/ol.2022.13312 |
Ejemplares similares
-
Chromatin regulators in retinoblastoma: Biological roles and therapeutic applications
por: Lee, Chunsik, et al.
Publicado: (2020) -
UHRF1 depletion sensitizes retinoblastoma cells to chemotherapeutic drugs via downregulation of XRCC4
por: He, Heng, et al.
Publicado: (2018) -
UHRF1 downmodulation enhances antitumor effects of histone deacetylase inhibitors in retinoblastoma by augmenting oxidative stress‐mediated apoptosis
por: Kim, Jong Kyong, et al.
Publicado: (2019) -
Targeting of histone methyltransferase DOT1L plays a dual role in chemosensitization of retinoblastoma cells and enhances the efficacy of chemotherapy
por: Mao, Yu, et al.
Publicado: (2021) -
Genomics and Therapeutic Vulnerabilities of Primary Bone Tumors
por: Scotlandi, Katia, et al.
Publicado: (2020)